IL6 and hepatocellular carcinoma: Because of anti-PD-L1 resistance in hepatocellular carcinoma, CAFs expressing high levels of IL-6 support the disruption of tumor-infiltrating T-cell function, resulting in the generation of immunosuppressive cells in the TME [133].